X2Z.F SKOTAN S.A. ZY 244
- Market cap
- EUR 10.4M
- P/E
- -
- P/B
- 15.80x
- ROE
- -124.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is X2Z.F undervalued?
Graham numberThe Graham number of SKOTAN S.A. ZY 244 cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
SKOTAN S.A. ZY 244 fundamental analysis
No fundamental analysis for SKOTAN S.A. ZY 244 yet.
SKOTAN S.A. ZY 244 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About SKOTAN S.A. ZY 244
onesano S.A. engages in the production of products related to nutritional cycle, from agricultural production, through animal breeding, to dietetics and human supplementation in Poland. The company offers omega-3, 6, and 9 fatty acids; postbiotic Yarrowia lipolytica Novel Food, solutions in animal nutrition and dietetics; solutions in the field of bioremediation for hydrocarbon-contaminated soil based on the unique postbiotic Yarrowia lipolytica; veterinary products. It also…
Full company profileSKOTAN S.A. ZY 244 financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
SKOTAN S.A. ZY 244 annual financial statements (PLN; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 11.5M | 12.1M | 12.2M | 10.7M | 11.9M | 13.3M |
| Gross Profit | 7.84M | 6.11M | 4.97M | 4.65M | 4.57M | 4.04M |
| Operating Income | -1.13M | -3.04M | -6.72M | -6.17M | -4.59M | -3.91M |
| EBITDA | - | -2.58M | -5.71M | -4.93M | -4.10M | -3.21M |
| Net Income | -1.21M | -3.93M | -6.36M | -5.80M | -4.79M | -3.73M |
| EPS | -0.03 | -0.06 | -0.10 | -0.09 | -0.07 | -0.06 |
| Balance Sheet | ||||||
| Total Assets | 5.74M | 25.7M | 19.7M | 12.8M | 9.26M | 7.63M |
| Total Liabilities | 18.9M | 3.92M | 4.28M | 3.18M | 4.40M | 4.63M |
| Shareholders' Equity | -13.1M | 21.8M | 15.5M | 9.66M | 4.87M | 3.00M |
| Cash & Short-term Investments | 59.0K | 19.0M | 10.4M | 3.37M | 314K | 232K |
| Cash Flow | ||||||
| Operating Cash Flow | 9.00K | -3.72M | -7.68M | -6.29M | -3.18M | -184K |
| Capital Expenditure | 44.0K | 115K | 738K | 551K | 170K | 0.00 |
| Free Cash Flow | -35.0K | -3.84M | -8.42M | -6.84M | -3.35M | -204K |
| Ratios | ||||||
| ROE | - | -18.0% | -41.2% | -60.0% | -98.5% | -124.4% |
| ROA | -21.0% | -15.3% | -32.2% | -45.2% | -51.7% | -48.9% |
| Net Profit Margin | -10.5% | -32.4% | -52.3% | -54.2% | -40.2% | -28.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
SKOTAN S.A. ZY 244 dividends
SKOTAN S.A. ZY 244 has not paid dividends in the last 5 fiscal years.
Who owns SKOTAN S.A. ZY 244
- Insiders 51.07%
- Institutions 0.00%
- Public & others 48.93%
- Shares outstanding 65.9M
- Free float 32.2M
SKOTAN S.A. ZY 244 company profile
- Company name
- SKOTAN S.A. ZY 244
- Ticker
- X2Z.F
- ISIN
- PLSKTAN00010
- Exchange
- Frankfurt Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 42
- Fiscal year end
- December
- Address
- ul. Dyrekcyjna 6, Chorzów, Poland, 41-506
- Phone
- 48 32 793 72 71
- Website
- onesano.pl
About SKOTAN S.A. ZY 244
onesano S.A. engages in the production of products related to nutritional cycle, from agricultural production, through animal breeding, to dietetics and human supplementation in Poland. The company offers omega-3, 6, and 9 fatty acids; postbiotic Yarrowia lipolytica Novel Food, solutions in animal nutrition and dietetics; solutions in the field of bioremediation for hydrocarbon-contaminated soil based on the unique postbiotic Yarrowia lipolytica; veterinary products. It also provides dietary supplements and nutraceuticals under the EstroVita and PostVital brands; veterinary products under the Equinox and Canifelox brands; fortified foods and feed products; and natural agricultural products, as well as the production of contract brands and food raw materials. It sells its products through chain pharmacies, pharmaceutical wholesalers, drugstores, and develops sales through e-commerce platforms. The company was formerly known as Skotan SA and changed its name to onesano S.A. in March 2023. onesano S.A. was incorporated in 2001 and is headquartered in Chorzów, Poland.
SKOTAN S.A. ZY 244 management
5- Ms. Dominika KowalczykPresident of the Management Board
- Piotr KrzakOperations Manager
- Wioletta SyposzChief Accountant
- Slawomir PaluchHead of Production & Technical Department
- Karolina LapsaHead of Laboratory and Quality Control Department & Quality Management Department Coordinator